Recently, Noack et al. identified a synthetic lethality between volasertib and paclitaxel in ovarian cancer cell lines with CCNE1-amplification, demonstrating that the combination induces a prolonged mitotic arrest and cell death, shifting the balance between pro- and anti-apoptotic proteins toward cell death [42]. Here, CCNE1 is linked to ovarian carcinoma.